此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Effects of Kinesiotaping in Osteoarthritis (Taping)

2026年5月20日 更新者:Nazli Cigercioglu

Effects of Adding Kinesiotaping to Conventional Physiotherapy on Pain, Function, and Kinesiophobia in Knee Osteoarthritis: A Randomized Controlled Trial

Knee osteoarthritis will be recognized as a leading cause of pain and functional disability, and conventional physiotherapy will remain a cornerstone of its management. Kinesiotaping will be widely used as an adjunct intervention; however, its additional benefit beyond standard rehabilitation programs will remain unclear.

This study will aim to investigate the additional effects of kinesiotaping combined with a conventional physiotherapy and rehabilitation program on pain, functional status, and kinesiophobia in individuals with unilateral knee osteoarthritis.

A total of 60 participants with unilateral knee osteoarthritis will be included in this randomized controlled trial and will be assigned to either a conventional physiotherapy (CP) group or a kinesiotaping (KT) group. Both groups will receive a 4-week (12 sessions) physiotherapy program including ultrasound, transcutaneous electrical nerve stimulation, patellofemoral mobilization, and exercise. Kinesiotaping will be applied every 3 days in the KT group. Outcome measures will include pain (VAS), kinesiophobia (TSK, FABQ), functional performance (30-s sit-to-stand, stair climb test), dynamic balance (functional reach), and WOMAC.

研究概览

地位

尚未招聘

条件

详细说明

Knee osteoarthritis will be recognized as a leading cause of pain and functional disability, and conventional physiotherapy will remain a cornerstone of its management. Kinesiotaping will be widely used as an adjunct intervention; however, its additional benefit beyond standard rehabilitation programs will remain unclear.

This study will aim to investigate the additional effects of kinesiotaping combined with a conventional physiotherapy and rehabilitation program on pain, functional status, and kinesiophobia in individuals with unilateral knee osteoarthritis.

A total of 60 participants with unilateral knee osteoarthritis will be included in this randomized controlled trial and will be assigned to either a conventional physiotherapy (CP) group or a kinesiotaping (KT) group. Both groups will receive a 4-week (12 sessions) physiotherapy program including ultrasound, transcutaneous electrical nerve stimulation, patellofemoral mobilization, and exercise. Kinesiotaping will be applied every 3 days in the KT group. Outcome measures will include pain (VAS), kinesiophobia (TSK, FABQ), functional performance (30-s sit-to-stand, stair climb test), dynamic balance (functional reach), and WOMAC.

研究类型

介入性

注册 (估计的)

60

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

  • 姓名:Nazli Assoc. Prof. Nazli Cigercioglu, Assoc. Prof.
  • 电话号码:+90 541 290 32 93
  • 邮箱:nazlicigercioglu@gmail.com

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人

接受健康志愿者

是的

描述

Inclusion Criteria:

  • Diagnosis of unilateral grade 2 knee osteoarthritis,
  • Age between 40 and 65 years,
  • Ability to understand and comply with assessments and interventions,
  • Independent ambulation without assistive devices,
  • No participation in a physiotherapy program for knee-related complaints within the previous year

Exclusion Criteria:

  • History of lower extremity surgery or trauma,
  • Presence of neurological or orthopedic conditions affecting gait or physical function,
  • Allergic reaction to kinesiotape,
  • Inability to walk independently.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:不适用
  • 介入模型:顺序分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Kinesiotaping
Kinesiotaping

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Kinesiophobia
大体时间:4 weeks
Kinesiophobia will evaluated using the Tampa Scale of Kinesiophobia (TSK) and the Fear-Avoidance Beliefs Questionnaire (FABQ). The TSK is a 17-item questionnaire scored on a 4-point Likert scale (1 = strongly disagree to 4 = strongly agree), with total scores ranging from 17 to 68, where higher scores indicate greater fear of movement. The FABQ assesses fear-avoidance beliefs related to physical activity and has been widely used in musculoskeletal disorders.
4 weeks

次要结果测量

结果测量
措施说明
大体时间
Pain intensity
大体时间:4 weeks
Pain intensity will be assessed using the Visual Analog Scale (VAS), a 10-cm horizontal line ranging from "no pain" (0) to "worst imaginable pain" . Participants will be asked to indicate the intensity of their knee pain during activity, and the marked distance will be measured in centimeters
4 weeks
Functional status
大体时间:4 weeks
Functional status will be assessed using performance-based tests. The 30-Second Sit-to-Stand Test will be used to evaluate lower extremity muscle strength and endurance. Participants will be instructed to stand up and sit down as many times as possible within 30 seconds, and the total number of repetitions will be recorded .
4 weeks
Functional mobility
大体时间:4 weeks
The 12-Step Stair Climb Test will be used to assess functional mobility and lower limb performance. Participants will be asked to ascend and descend a 12-step staircase as quickly and safely as possible, and the total time taken to complete the task will be recorded in seconds .
4 weeks
Dynamic balance
大体时间:4 weeks
Dynamic balance will be evaluated using the Functional Reach Test. Participants will be instructed to stand upright and reach forward as far as possible without losing balance or taking a step. The maximum distance reached will be measured in centimeters .
4 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Cigercioglu、Hacettepe University

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年6月20日

初级完成 (估计的)

2026年12月20日

研究完成 (估计的)

2027年6月20日

研究注册日期

首次提交

2026年5月7日

首先提交符合 QC 标准的

2026年5月20日

首次发布 (实际的)

2026年5月26日

研究记录更新

最后更新发布 (实际的)

2026年5月26日

上次提交的符合 QC 标准的更新

2026年5月20日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

关键字

其他研究编号

  • OA_RCS_2026

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

未定

IPD 计划说明

It will be provided upon request if deemed necessary.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅